Study finds early referrals to hospice care can improve patients’ quality of life and reduce unnecessary emergency room admissions
Read MoreHNSCC: Outpatient ChemoRT Regimen Offers Outcomes Equal to Inpatient at Lower Cost
Head-to-head study analyzing both costs and outcomes in outpatient vs. inpatient regimens finds no difference clinically but lower cost for outpatient therapy.
Radiation Therapy Oncology Group Top Enroller
Last year, Cleveland Clinic’s Department of Radiation Oncology enrolled over 100 patients in Radiation Therapy Oncology Group clinical trials, topping recruitment numbers of all members of the research cooperative.
Researchers Find Mutation That Promotes Hormone Therapy Resistance
Cleveland Clinic researchers have discovered the first example of a genetic alteration that increases the conversion of precursor steroids to 5α-dihydrotestosterone (DHT), permitting prostate tumors to grow in the absence of gonadal testosterone.
April Featured Clinical Trials
Learn about featured clinical trials currently enrolling or search our trials database.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Research Shows HDL Has Cancer-Fighting Ability
Apolipoprotein A1, a major component of HDL, blocks metastatic malignant melanoma and lung cancer through multiple pathways. ApoA1 injections not only inhibit tumor growth and progression in mice, but spur tumor and metastases regression.